DOI QR코드

DOI QR Code

Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary Atresia

  • Anna Degtyareva (Department of Pediatric, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology) ;
  • Medan Isaeva (Department of Research, NPF DNA-Technology LLC.) ;
  • Elena Tumanova (Department of Pathological Anatomy and Clinical Pathological Anatomy, Pirogov Russian National Research Medical University) ;
  • Elena Filippova (Department of Ultrasound Diagnostics in Neonatology and Pediatrics, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology) ;
  • Anna Sugak (Department of Ultrasound Diagnostics in Neonatology and Pediatrics, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology) ;
  • Alexander Razumovsky (Division of Thoracic Surgery, Department of Moscow Healthcare, Filatov Children's City Clinical Hospital) ;
  • Nadezhda Kulikova (Division of Thoracic Surgery, Department of Moscow Healthcare, Filatov Children's City Clinical Hospital) ;
  • Marina Albegova (Department of Pediatric, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology) ;
  • Denis Rebrikov (Institute of Translational Medicine, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology)
  • 투고 : 2024.01.10
  • 심사 : 2024.04.21
  • 발행 : 2024.07.15

초록

Purpose: Biliary atresia (BA) is the leading cause of neonatal cholestasis (25-45%). The primary treatment is hepatic portoenterostomy (Kasai procedure), but only 20-40% provide long-term benefits. This study aimed to develop a predictive model for surgical efficacy by comparing preoperative and early postoperative indicators in infants with different outcomes. Methods: We enrolled 166 infants with BA (93 girls, 73 boys) who underwent the Kasai procedure between September 2002 and December 2021, dividing them into favorable or adverse outcome groups. Over 40 parameters were measured, and the diagnostic significance of the prognostic model was evaluated. Results: Kasai surgery was efficacious in 69 patients (42%) and non-efficacious in 97 (58%). Our model assesses efficacy by day 14 after surgery, improving on the <34 µmol/L direct bilirubin threshold established for 3-6 months after the procedure. Including the Desmet fibrosis score refined the model. Conclusion: Blood cholesterol below 5.41 mmol/L, direct bilirubin below 56.3 µmol/L on postoperative days 14±3, and a low Desmet score indicate a high probability of efficacious Kasai surgery in infants with BA.

키워드

참고문헌

  1. Feldman AG, Sokol RJ. Recent developments in diagnostics and treatment of neonatal cholestasis. Semin Pediatr Surg 2020;29:150945.
  2. Wong CWY, Chung PHY, Tam PKH, Wong KKY. Long-term results and quality of life assessment in biliary atresia patients: a 35-year experience in a tertiary hospital. J Pediatr Gastroenterol Nutr 2018;66:570-4.
  3. Jain V, Burford C, Alexander EC, Sutton H, Dhawan A, Joshi D, et al. Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J Hepatol 2019;71:71-7.
  4. Ryon EL, Parreco JP, Sussman MS, Quiroz HJ, Willobee BA, Perez EA, et al. Drivers of hospital readmission and early liver transplant after Kasai portoenterostomy. J Surg Res 2020;256:48-55.
  5. Tam PKH, Chung PHY, St Peter SD, Gayer CP, Ford HR, Tam GCH, et al. Advances in paediatric gastroenterology. Lancet 2017;390:1072-82.
  6. Liu L, Wei L, Qu W, Liu Y, Zeng Z, Zhang H, et al. Impact of the Kasai procedure and the length of native liver survival time on outcomes of liver transplantation for biliary atresia. Liver Transpl 2022;28:224-35.
  7. Ramos-Gonzalez G, Elisofon S, Dee EC, Staffa SJ, Medford S, Lillehei C, et al. Predictors of need for liver transplantation in children undergoing hepatoportoenterostomy for biliary atresia. J Pediatr Surg 2019;54:1127-31.
  8. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148:467-74.
  9. Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, et al. Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J Pediatr 2016;170:211-7.e1-2.
  10. Kumar R, Lal BB, Sood V, Khanna R, Kumar S, Bharathy KGS, et al. Predictors of successful Kasai portoenterostomy and survival with native liver at 2 years in infants with biliary atresia. J Clin Exp Hepatol 2019;9:453-9.
  11. Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg 2011;254:577-85.
  12. Huang CY, Chang MH, Chen HL, Ni YH, Hsu HY, Wu JF. Bilirubin level 1 week after hepatoportoenterostomy predicts native liver survival in biliary atresia. Pediatr Res 2020;87:730-4.
  13. Abdel-Aziz SA, Sira MM, Gad EH, Ayoub I, Soltan M. Preoperative alkaline phosphatase is a potential predictor of short-term outcome of surgery in infants with biliary atresia. Clin Exp Hepatol 2019;5:155-60.
  14. Ihn K, Ho IG, Chang EY, Han SJ. Correlation between gamma-glutamyl transpeptidase activity and outcomes after Kasai portoenterostomy for biliary atresia. J Pediatr Surg 2018;53:461-7.
  15. Capparelli MA, Ayarzabal VH, Halac ET, Questa HA, Minetto MJ, Cervio G, et al. Preoperative risk factors for the early failure of the Kasai portoenterostomy in patients with biliary atresia. Pediatr Surg Int 2021;37:1183-9.
  16. Redkar R, Raj V, Chigicherla S, Tewari S, Tampi C, Joshi S. Risk prediction scoring system to predict the postsurgical outcomes of biliary atresia. J Indian Assoc Pediatr Surg 2020;25:280-5.
  17. Hukkinen M, Pihlajoki M, Pakarinen MP. Predicting native liver injury and survival in biliary atresia. Semin Pediatr Surg 2020;29:150943.
  18. Khanna K, Bhatnagar V, Agarwala S, Srinivas M, Gupta SD. Ratio of preoperative and postoperative serum bilirubin levels predicts early outcome following biliary atresia surgery. J Indian Assoc Pediatr Surg 2018;23:81-6.
  19. Nguyen AP, Pham YHT, Vu GH, Nguyen MH, Hoang TN, Holterman A. Biliary atresia liver histopathological determinants of early post-Kasai outcome. J Pediatr Surg 2021;56:1169-73.
  20. Chiang LW, Lee CY, Krishnaswamy G, Nah SA, Kader A, Ong C, et al. Seventeen years of Kasai portoenterostomy for biliary atresia in a single Southeast Asian paediatric centre. J Paediatr Child Health 2017;53:412-5.
  21. Goda T, Kawahara H, Kubota A, Hirano K, Umeda S, Tani G, et al. The most reliable early predictors of outcome in patients with biliary atresia after Kasai's operation. J Pediatr Surg 2013;48:2373-7.
  22. Razumovskiy AY, Degtyareva AV, Kulikova NV, Ratnikov SA. [Advantages of Kasai procedure through minimally invasive approach in children with biliary atresia (in Russian only)]. Khirurgiia (Mosk) 2019;(3):48-59. Russian.
  23. Yassin NA, El-Tagy G, Abdelhakeem ON, Asem N, El-Karaksy H. Predictors of short-term outcome of Kasai portoenterostomy for biliary atresia in infants: a single-center study. Pediatr Gastroenterol Hepatol Nutr 2020;23:266-75.
  24. Chung PH, Wong KK, Tam PK. Predictors for failure after Kasai operation. J Pediatr Surg 2015;50:293-6.
  25. Fanna M, Masson G, Capito C, Girard M, Guerin F, Hermeziu B, et al. Management of biliary atresia in France 1986 to 2015: long-term results. J Pediatr Gastroenterol Nutr 2019;69:416-24.
  26. Ramachandran P, Safwan M, Srinivas S, Shanmugam N, Vij M, Rela M. The extended Kasai portoenterostomy for biliary atresia: a preliminary report. J Indian Assoc Pediatr Surg 2016;21:66-71.
  27. Udomsinprasert W, Honsawek S, Anomasiri W, Chongsrisawat V, Vejchapipat P, Poovorawan Y. Elevated adiponectin is associated with poor outcome in children with biliary atresia. Asian Biomed 2012;6:369-76.
  28. Sun S, Zheng S, Lu X, Chen G, Ma Y, Chen L, et al. Clinical and pathological features of patients with biliary atresia who survived for more than 5 years with native liver. Pediatr Surg Int 2018;34:381-6.